Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 5, 1997

View Archived Issues

Fullerene derivative with vasorelaxant effects described by Japanese academics

Licensing agreement signed for OxSODrol

Xenova: half-year 1997 highlights

Antioxidant from Otsuka effective in animal model of nephritis

Generic methylphenidate approved in U.S.

Beneficial effects of TDN-345 in animal models of cerebrovascular disease

Novartis migraine treatment nears U.S. approval

Nicotinic agonist protects against neuronal cell death in rodents

Summary of azelnidipine preclinical data

Russian scientists report on myelopeptides

RPR scientists try a new approach to gpIIb/IIIa antagonists

New antitumor agents from Kyorin and Sagami

SmithKline Beecham synthesizes mechanism-based HSV protease inhibitors

Celgene claims PDE/TNF/NFkappaB inhibitors

Vitamin D derivatives as progesterone antagonists

Warner-Lambert reports novel MMP inhibitors

Antimitotic cryptophycin compounds

Warner-Lambert/CoCensys disclose subtype-selective NMDA antagonists

AWD-140-190: new anticonvulsant with favorable efficacy and safety profile

New 5-HT3 receptor ligand with agonist activity in the gut

Roche seeks European approval for humanized monoclonal antibody

SK-946: a potent and selective muscarinic M1 receptor agonist from Sanwa Kagaku

T-686 inhibits thrombus formation without hemostatic impairment

U.S. patent covering novel CPC-111 formulation

Axcan completes acquisition of U.S. rights to Viokase

RTP licenses improved propofol formulation to AMRAD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...